Citation Impact
Citing Papers
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
Disruption of MyD88 signaling suppresses hemophagocytic lymphohistiocytosis in mice
2011 StandoutNobel
Structure and Function of the Complement Receptors, CR1 (CD35) and CR2 (CD21)
1989
Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules
1995
Herpes simplex virus type 1 glycoprotein C is necessary for efficient infection of chondroitin sulfate-expressing gro2C cells
2002
Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B
1994
Peroxisome Proliferator-activated Receptor γ Coactivator 1β (PGC-1β), A Novel PGC-1-related Transcription Coactivator Associated with Host Cell Factor
2002
Heparin-Protein Interactions
2002 Standout
Crystal Structure of the HSV-1 Fc Receptor Bound to Fc Reveals a Mechanism for Antibody Bipolar Bridging
2006 StandoutNobel
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
Comparative Biology of Latent Varicella-Zoster Virus and Herpes Simplex VirusInfections
1992
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
1993 Standout
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
1996 Standout
The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol
1996 Standout
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
1999 Standout
Expression of Epstein–Barr virus gp350 as a single chain glycoprotein for an EBV subunit vaccine
1999
Herpes Simplex Viruses
1998
Hypomorphic Mutation in the Site-1 Protease Mbtps1 Endows Resistance to Persistent Viral Infection in a Cell-Specific Manner
2011 StandoutNobel
Decreased herpes simplex viral immunity and enhanced pathogenesis following stressor administration in mice
1992
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells
1993 StandoutNature
CpG motifs in bacterial DNA trigger direct B-cell activation
1995 StandoutNature
Clockwork Orange is a transcriptional repressor and a new Drosophila circadian pacemaker component
2007 StandoutNobel
The phasevarion: phase variation of type III DNA methyltransferases controls coordinated switching in multiple genes
2010
A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes
1994
PRDM16 controls a brown fat/skeletal muscle switch
2008 StandoutNature
Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice
2005
SUMO
2005 Standout
An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ
1994
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
The immune system in atherosclerosis
2011 Standout
Herpes Simplex Virus Infection of Dendritic Cells: Balance among Activation, Inhibition, and Immunity
2003
Herpes simplex virus type 1 mutants for the origin-binding protein induce DNA amplification in the absence of viral replication
1990 StandoutNobel
The herpes simplex virus VP16-induced complex: the makings of a regulatory switch
2003
Circadian Transcription Contributes to Core Period Determination in Drosophila
2008 StandoutNobel
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity
2014
Metabolic control through the PGC-1 family of transcription coactivators
2005 Standout
Anatomy of Viral Persistence: Mechanisms of Persistence and Associated Disease
1996
Molecular Basis of Latency in Pathogenic Human Viruses
1991 Science
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Transcription of HERV-E and HERV-E-related sequences in malignant and non-malignant human haematopoietic cells
2008 StandoutNobel
Stress-induced immune dysfunction: implications for health
2005 Standout
The octamer binding factor Oct6: cDNA cloning and expression in early embryonic cells
1990
Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
2002 StandoutNature
Expression of a functional foreign gene in adult mammalian brain following in Vivo transfer via a herpes simplex virus type 1 defective viral vector
1991
Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data
2013 Standout
Oncogenic DNA viruses
2001 StandoutNobel
Subversion of the immune system by pathogens
1994
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
A novel form of Epstein-Barr virus latency in normal B cells in vivo
1995 Standout
Optogenetics in Neural Systems
2011 Standout
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
2010 StandoutScience
ICP0, a regulator of herpes simplex virus during lytic and latent infection
2000
Gene delivery and gene therapy with herpes simplex virus-based vectors
2001
Epstein–Barr Virus Infection
2000 Standout
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
1996 Standout
Characterization of the bovine herpesvirus 4 major immediate-early transcript
1991
Cell Biology of the Glomerular Podocyte
2003 Standout
Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells
1990
Peptide Antimicrobial Agents
2006 Standout
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Replacement mutagenesis of the human cytomegalovirus genome: US10 and US11 gene products are nonessential
1991
Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.
1991
Gamma Interferon (IFN-γ) Receptor Null-Mutant Mice Are More Susceptible to Herpes Simplex Virus Type 1 Infection than IFN-γ Ligand Null-Mutant Mice
1999
Epstein-Barr Virus Binding to CD21 Activates the Initial Viral Promoter via NF-κB Induction
1997
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells
1994
Nonviral Vectors for Gene Delivery
2008 Standout
Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α (PGC-1α): Transcriptional Coactivator and Metabolic Regulator
2003 Standout
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.
1996 Standout
Long-Distance Neuronal Migration in the Adult Mammalian Brain
1994 StandoutScience
Herpes Simplex Viruses
2002
Cell surface proteoglycans are not essential for infection by pseudorabies virus
1995
Antiviral Actions of Interferons
2001 Standout
Multiple Immediate-Early Gene-Deficient Herpes Simplex Virus Vectors Allowing Efficient Gene Delivery to Neurons in Culture and Widespread Gene Delivery to the Central Nervous System In Vivo
2001
A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome
1989 StandoutNobel
Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry
1996
Association of C-Terminal Ubiquitin Hydrolase BRCA1-Associated Protein 1 with Cell Cycle Regulator Host Cell Factor 1
2009
Mapping of Herpes Simplex Virus-1 Neurovirulence to γ 1 34.5, a Gene Nonessential for Growth in Culture
1990 Science
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
2020 StandoutNobel
Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4
1995
An analysis of vertebrate mRNA sequences: intimations of translational control.
1991 Standout
Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity.
1987 StandoutNobel
Microtubule-mediated Transport of Incoming Herpes Simplex Virus 1 Capsids to the Nucleus
1997
Short Interfering RNA-Mediated Inhibition of Herpes Simplex Virus Type 1 Gene Expression and Function during Infection of Human Keratinocytes
2004 StandoutNobel
Antiviral effect of an oligo(nucleoside methylphosphonate) complementary to the splice junction of herpes simplex virus type 1 immediate early pre-mRNAs 4 and 5.
1986
The adeno-associated virus rep gene suppresses herpes simplex virus-induced DNA amplification
1990 StandoutNobel
Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III
2000 StandoutNobel
Persistence and Expression of the Herpes Simplex Virus Genome in the Absence of Immediate-Early Proteins
1998
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Responses of Herpes Simplex Virus Type 1-Infected Cells to the Presence of Extracellular Antibodies: gE-Dependent Glycoprotein Capping and Enhancement in Cell-to-Cell Spread
2002
Works of Amy E. Sears being referenced
An Inquiry into the Mechanisms of Herpes Simplex Virus Latency
1987
Characterization of the Type III restriction endonuclease PstII from Providencia stuartii
2005
Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus I
1988
Subunit assembly modulates the activities of the Type III restriction-modification enzyme PstII in vitro
2005
Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice
1985
Expression of the herpes simplex virus 1 alpha transinducing factor (VP16) does not induce reactivation of latent virus or prevent the establishment of latency in mice
1991
Herpes Simplex Virus Inhibits Apoptosis through the Action of Two Genes, Us5 and Us3
1999
Infection of polarized MDCK cells with herpes simplex virus 1: two asymmetrically distributed cell receptors interact with different viral proteins.
1991
Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes
1988
Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency
1999